Deutsche Bank’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Deutsche Bank’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-265,076	Closed	-$26.7M	–	6495
2014 Q4	$26.7M	Sell	265,076 -442,122	-63%	-$34.4M	0.02%	858
2014 Q3	$46.9M	Sell	707,198 -566,785	-44%	-$37.2M	0.03%	559
2014 Q2	$88.9M	Buy	1,273,983 +479,066	+60%	+$32.6M	0.06%	373
2014 Q1	$58.1M	Sell	794,917 -330,076	-29%	-$24.6M	0.04%	469
2013 Q4	$77.5M	Buy	1,124,993 +230,578	+26%	+$14.9M	0.06%	383
2013 Q3	$56.8M	Sell	894,415 -246,891	-22%	-$14.9M	0.04%	454
2013 Q2	$55.1M	Buy	+1,141,306	New	+$56.1M	0.05%	434

Deutsche Bank's CBST Position: Q1 2015 in Review

Deutsche Bank sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 265,076 shares — an estimated $26.7M sold.

Deutsche Bank first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $88.9M in Q2 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Deutsche Bank reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 265,076 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $26.7M.
Deutsche Bank first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Deutsche Bank's CUBIST PHARMACEUTICALS INC position peaked at $88.9M in Q2 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.